FibroBiologics, Inc. Common Stock (FBLG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $6.57M
Last updated: Nov 17, 2026 at 11:01 AM ET
FibroBiologics, Inc. Common Stock (FBLG) Earnings: Report Dates and Results
FibroBiologics, Inc. Common Stock (FBLG) is expected to report earnings on Feb 22, 2027. In the quarter ended Sep 30, 2026, FibroBiologics, Inc. Common Stock reported EPS of -$2.60, below the -$0.63 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
FBLG has an expected report date of Feb 22, 2027.
Earnings History
Of the 10 quarters below that had an estimate, FBLG beat 5, missed 3 and matched 2. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 312.70% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$2.60 | -$0.63 | -$0.63 - -$0.63 | -312.70% | Miss | N/A | 1 | 1 up, 0 down | Nov 13, 2026 |
| Jun 30, 2026 | -$0.66 | -$0.93 | -$0.93 - -$0.93 | +29.03% | Beat | N/A | 1 | 1 up, 0 down | Jul 31, 2026 |
| Mar 31, 2026 | -$1.33 | -$1.36 | -$1.40 - -$1.31 | +1.84% | Beat | N/A | 2 | 1 up, 0 down | Apr 30, 2026 |
| Dec 31, 2025 | -$0.60 | -$2.00 | -$2.00 - -$2.00 | +70.00% | Beat | N/A | 2 | 1 up, 1 down | Feb 24, 2026 |
| Sep 30, 2025 | -$2.60 | -$2.30 | -$2.40 - -$2.20 | -13.04% | Miss | N/A | 2 | 1 up, 0 down | Oct 31, 2025 |
| Jun 30, 2025 | -$0.12 | -$0.12 | -$0.12 - -$0.12 | 0.00% | In line | -120.0% | 2 | 1 up, 1 down | Jul 31, 2025 |
| Mar 31, 2025 | -$2.80 | -$2.50 | -$2.80 - -$2.20 | -12.00% | Miss | N/A | 2 | 0 up, 0 down | May 14, 2025 |
| Dec 31, 2024 | -$0.09 | -$0.09 | N/A | 0.00% | In line | N/A | 1 | 0 up, 0 down | Mar 27, 2025 |
| Sep 30, 2024 | -$0.20 | -$1.73 | N/A | +88.44% | Beat | N/A | 1 | 0 up, 0 down | Nov 12, 2024 |
| Jun 30, 2024 | $0.60 | -$1.80 | N/A | +133.33% | Beat | N/A | N/A | N/A | Aug 7, 2024 |
| Mar 31, 2024 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2024 |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was -$5.19, after -$3.21 the year before. It was $0.33 for the year ended Jun 30, 2024, the oldest of the 3 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | -$5.19 | N/A |
| Jun 30, 2025 | -$3.21 | -1072.7% |
| Jun 30, 2024 | $0.33 | N/A |
Frequently Asked Questions About FBLG
When is FibroBiologics, Inc. Common Stock's next earnings date?
FibroBiologics, Inc. Common Stock's next earnings report is expected for Feb 22, 2027.
Did FBLG beat earnings estimates last quarter?
No. FibroBiologics, Inc. Common Stock reported EPS of -$2.60 for the quarter ended Sep 30, 2026, below the -$0.63 estimate by 312.70%.
What EPS do analysts expect from FBLG next quarter?
The consensus EPS estimate for FibroBiologics, Inc. Common Stock for the quarter ending Dec 31, 2026 is -$0.64 from 3 analysts.
How often does FBLG beat earnings estimates?
FibroBiologics, Inc. Common Stock beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of -29.61%.
FBLG pages: Overview, Earnings, Forecast, Financials, Competitors